A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism

David S Geller; Junhui Zhang; Max V Wisgerhof; Cedric Shackleton; Michael Kashgarian; Richard P Lifton

doi:10.1210/jc.2008-0594

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism

David S Geller
, Junhui Zhang
, Max V Wisgerhof
, Cedric Shackleton
, Michael Kashgarian
, Richard P Lifton

Research output: Contribution to journal › Article › peer-review

193 Citations (Scopus)

Abstract

Primary aldosteronism is a leading cause of secondary hypertension (HTN), but the mechanisms underlying the characteristic renin-independent secretion of aldosterone remain unknown in most patients.

Original language	English
Pages (from-to)	3117-23
Number of pages	7
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	93
Issue number	8
DOIs	https://doi.org/10.1210/jc.2008-0594
Publication status	Published - 2008

Access to Document

10.1210/jc.2008-0594

Cite this

@article{b195852cbcc74eaf924adef53090e864,

title = "A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism",

abstract = "Primary aldosteronism is a leading cause of secondary hypertension (HTN), but the mechanisms underlying the characteristic renin-independent secretion of aldosterone remain unknown in most patients.",

author = "Geller, \{David S\} and Junhui Zhang and Wisgerhof, \{Max V\} and Cedric Shackleton and Michael Kashgarian and Lifton, \{Richard P\}",

year = "2008",

doi = "10.1210/jc.2008-0594",

language = "English",

volume = "93",

pages = "3117--23",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Endocrine Society",

number = "8",

}

TY - JOUR

T1 - A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism

AU - Geller, David S

AU - Zhang, Junhui

AU - Wisgerhof, Max V

AU - Shackleton, Cedric

AU - Kashgarian, Michael

AU - Lifton, Richard P

PY - 2008

Y1 - 2008

N2 - Primary aldosteronism is a leading cause of secondary hypertension (HTN), but the mechanisms underlying the characteristic renin-independent secretion of aldosterone remain unknown in most patients.

AB - Primary aldosteronism is a leading cause of secondary hypertension (HTN), but the mechanisms underlying the characteristic renin-independent secretion of aldosterone remain unknown in most patients.

U2 - 10.1210/jc.2008-0594

DO - 10.1210/jc.2008-0594

M3 - Article

C2 - 18505761

SN - 0021-972X

VL - 93

SP - 3117

EP - 3123

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 8

ER -

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism

Abstract

Access to Document

Fingerprint

Cite this